These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

174 related articles for article (PubMed ID: 21493752)

  • 21. Inhibition of 3,4-methylenedioxymethamphetamine metabolism leads to marked decrease in 3,4-dihydroxymethamphetamine formation but no change in serotonin neurotoxicity: implications for mechanisms of neurotoxicity.
    Mueller M; Yuan J; Maldonado Adrian C; McCann UD; Ricaurte GA
    Synapse; 2011 Oct; 65(10):983-90. PubMed ID: 21360595
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Neurotoxic thioether adducts of 3,4-methylenedioxymethamphetamine identified in human urine after ecstasy ingestion.
    Perfetti X; O'Mathúna B; Pizarro N; Cuyàs E; Khymenets O; Almeida B; Pellegrini M; Pichini S; Lau SS; Monks TJ; Farré M; Pascual JA; Joglar J; de la Torre R
    Drug Metab Dispos; 2009 Jul; 37(7):1448-55. PubMed ID: 19349378
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Synthesis and in vitro cytotoxicity profile of the R-enantiomer of 3,4-dihydroxymethamphetamine (R-(-)-HHMA): comparison with related catecholamines.
    Felim A; Herrera G; Neudörffer A; Blanco M; O'Connor JE; Largeron M
    Chem Res Toxicol; 2010 Jan; 23(1):211-9. PubMed ID: 20017534
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Non-linear pharmacokinetics of MDMA ('ecstasy') in humans.
    de la Torre R; Farré M; Ortuño J; Mas M; Brenneisen R; Roset PN; Segura J; Camí J
    Br J Clin Pharmacol; 2000 Feb; 49(2):104-9. PubMed ID: 10671903
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Urinary excretion kinetics of 3,4-methylenedioxymethamphetamine (MDMA, ecstasy) and its phase I and phase II metabolites in humans following controlled MDMA administration.
    Schwaninger AE; Meyer MR; Barnes AJ; Kolbrich-Spargo EA; Gorelick DA; Goodwin RS; Huestis MA; Maurer HH
    Clin Chem; 2011 Dec; 57(12):1748-56. PubMed ID: 21980168
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Stereochemical analysis of 3,4-methylenedioxymethamphetamine and its main metabolites in human samples including the catechol-type metabolite (3,4-dihydroxymethamphetamine).
    Pizarro N; Farré M; Pujadas M; Peiró AM; Roset PN; Joglar J; de la Torre R
    Drug Metab Dispos; 2004 Sep; 32(9):1001-7. PubMed ID: 15319342
    [TBL] [Abstract][Full Text] [Related]  

  • 27. MDMA and metabolite disposition in expectorated oral fluid after controlled oral MDMA administration.
    Barnes AJ; Scheidweiler KB; Kolbrich-Spargo EA; Gorelick DA; Goodwin RS; Huestis MA
    Ther Drug Monit; 2011 Oct; 33(5):602-8. PubMed ID: 21860342
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Oral fluid and plasma 3,4-methylenedioxymethamphetamine (MDMA) and metabolite correlation after controlled oral MDMA administration.
    Desrosiers NA; Barnes AJ; Hartman RL; Scheidweiler KB; Kolbrich-Spargo EA; Gorelick DA; Goodwin RS; Huestis MA
    Anal Bioanal Chem; 2013 May; 405(12):4067-76. PubMed ID: 23471370
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Disposition of methylenedioxymethamphetamine and three metabolites in the brains of different rat strains and their possible roles in acute serotonin depletion.
    Chu T; Kumagai Y; DiStefano EW; Cho AK
    Biochem Pharmacol; 1996 Mar; 51(6):789-96. PubMed ID: 8602874
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Lost in translation: preclinical studies on 3,4-methylenedioxymethamphetamine provide information on mechanisms of action, but do not allow accurate prediction of adverse events in humans.
    Green AR; King MV; Shortall SE; Fone KC
    Br J Pharmacol; 2012 Jul; 166(5):1523-36. PubMed ID: 22188379
    [TBL] [Abstract][Full Text] [Related]  

  • 31. A Case of 3,4-Dimethoxyamphetamine (3,4-DMA) and 3,4-Methylenedioxymethamphetamine (MDMA) Toxicity with Possible Metabolic Interaction.
    Darracq MA; Thornton SL; Minns AB; Gerona RR
    J Psychoactive Drugs; 2016; 48(5):351-354. PubMed ID: 27636207
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Impact of Cytochrome P450 2D6 Function on the Chiral Blood Plasma Pharmacokinetics of 3,4-Methylenedioxymethamphetamine (MDMA) and Its Phase I and II Metabolites in Humans.
    Steuer AE; Schmidhauser C; Tingelhoff EH; Schmid Y; Rickli A; Kraemer T; Liechti ME
    PLoS One; 2016; 11(3):e0150955. PubMed ID: 26967321
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Induction of glutathione synthesis and conjugation by 3,4-methylenedioxymethamphetamine (MDMA) and 3,4-dihydroxymethamphetamine (HHMA) in human and rat liver cells, including the protective role of some antioxidants.
    Antolino-Lobo I; Meulenbelt J; Molendijk J; Nijmeijer SM; Scherpenisse P; van den Berg M; van Duursen MB
    Toxicology; 2011 Nov; 289(2-3):175-84. PubMed ID: 21871945
    [TBL] [Abstract][Full Text] [Related]  

  • 34. A convenient biomimetic synthesis of optically active putative neurotoxic metabolites of MDMA ("ecstasy") from R-(-)- and S-(+)-N-methyl-α-methyldopamine precursors.
    Martinez CM; Neudörffer A; Largeron M
    Org Biomol Chem; 2012 May; 10(18):3739-48. PubMed ID: 22456797
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Simultaneous liquid chromatographic-electrospray ionization mass spectrometric quantification of 3,4-methylenedioxymethamphetamine (MDMA, Ecstasy) and its metabolites 3,4-dihydroxymethamphetamine, 4-hydroxy-3-methoxymethamphetamine and 3,4-methylenedioxyamphetamine in squirrel monkey and human plasma after acidic conjugate cleavage.
    Mueller M; Peters FT; Huestis MA; Ricaurte GA; Maurer HH
    Forensic Sci Int; 2009 Jan; 184(1-3):64-8. PubMed ID: 19131196
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Self-injection of d,1-3,4-methylenedioxymethamphetamine (MDMA) in the baboon.
    Lamb RJ; Griffiths RR
    Psychopharmacology (Berl); 1987; 91(3):268-72. PubMed ID: 2882537
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Evaluation of the Ecstasy influence on tramadol and its main metabolite plasma concentration in rats.
    Jamali B; Sheikholeslami B; Hosseinzadeh Ardakani Y; Lavasani H; Rouini MR
    Drug Metab Pers Ther; 2017 Sep; 32(3):137-145. PubMed ID: 28917081
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Distribution of 3,4-methylenedioxymethamphetamine (MDMA) and 3,4-methylenedioxyamphetamine (MDA) stereoisomers in a fatal poisoning.
    Moore KA; Mozayani A; Fierro MF; Poklis A
    Forensic Sci Int; 1996 Dec; 83(2):111-9. PubMed ID: 9022274
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Hair analysis for drug abuse. XV. Disposition of 3, 4-methylenedioxymethamphetamine (MDMA) and its related compounds into rat hair and application to hair analysis for MDMA abuse.
    Kikura R; Nakahara Y; Mieczkowski T; Tagliaro F
    Forensic Sci Int; 1997 Jan; 84(1-3):165-77. PubMed ID: 9042722
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Action of MDMA (ecstasy) and its metabolites on arginine vasopressin release.
    Fallon JK; Shah D; Kicman AT; Hutt AJ; Henry JA; Cowan DA; Forsling M
    Ann N Y Acad Sci; 2002 Jun; 965():399-409. PubMed ID: 12105115
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.